The FDA has approved Entereg (alvimopan capsules, from Adolor and GlaxoSmithKline) to accelerate upper and lower gastrointestinal (GI) recovery following resection surgery with primary anastomosis.

Entereg is a peripherally acting mu-opioid receptor (PAM-OR) antagonist and will be available for short-term use in hospitals registered under the Entereg Access Support and Education (E.A.S.E.) program starting in June 2008.

For more information call (888) 825-5249 or visit www.entereg.com.